Endocan and Major Adverse Cardiovascular Events: Understanding Regression Methods

被引：1
|
作者：
Aksu, Ugur [1 ]
Gulcu, Oktay [1 ]
Aksakal, Emrah [1 ]
Kalkan, Kamuran [1 ]
机构：
[1] Erzurum Training & Res Hosp, Dept Cardiol, Erzurum, Turkey
来源：
ANGIOLOGY | 2019年 / 70卷 / 10期
关键词：
endocan; mortality; myocardial infarction;
D O I：
10.1177/0003319719828911
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：982 / 982
页数：1
相关论文
共 50 条
  • [1] Elevated serum endocan levels are associated with major adverse cardiovascular events in patients with coronary artery disease
    Sun, Fuqing
    Chen, Yifei
    Lin, Yongfang
    Chen, Ping
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C209 - C209
  • [2] Predictive Value of Endocan Based on TIMI Risk Score on Major Adverse Cardiovascular Events After Acute Coronary Syndrome
    Ziaee, Mojtaba
    Mashayekhi, Sina
    Ghaffari, Samad
    Mahmoudi, Javad
    Sarbakhsh, Parvin
    Garjani, Alireza
    ANGIOLOGY, 2019, 70 (10) : 952 - 959
  • [3] Regression of Left Main Coronary Arterial Atherosclerosis: Implications for Major Adverse Cardiovascular Events
    Puri, Rishi
    Wolski, Kathy
    Uno, Kiyoko
    Kataoka, Yu
    King, Karilane L.
    Mayock, Erin
    Balazs, Eva
    Poliszczuk, Roman
    Magyar, William A.
    Crowe, Tim
    Kapadia, Samir R.
    Tuzcu, E. Murat
    Nissen, Steven E.
    Nicholls, Stephen J.
    CIRCULATION, 2011, 124 (21)
  • [4] Prediabetes and the Incidence of Major Adverse Cardiovascular Events
    Booth, Gillian L.
    Rezai, Mohammad R.
    Atzema, Clare
    Austin, Peter C.
    Bhatia, Sacha
    Bierman, Arlene S.
    Clemens, Kristin K.
    Johnston, Sharon
    Ko, Dennis T.
    Lee, Douglas S.
    Tu, Karen
    Tu, Jack V.
    DIABETES, 2017, 66 : A81 - A82
  • [5] A paradigm shift for cardiovascular outcome evaluation in diabetes: Major adverse cardiovascular events (MACE) to major adverse vascular events (MAVE)
    Rastogi, Ashu
    Sudhayakumar, Anand
    Schaper, Nicolaas C.
    Jude, Edward B.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (11)
  • [6] JAK inhibitors: risk of major adverse cardiovascular events
    Reactions Weekly, 2025, 2052 (1) : 8 - 8
  • [7] Prediabetes as a risk factor for major adverse cardiovascular events
    Mando, Ramy
    Waheed, Muhammad
    Michel, Adrian
    Karabon, Patrick
    Halalau, Alexandra
    ANNALS OF MEDICINE, 2021, 53 (01) : 2090 - 2098
  • [8] PREDIABETES ASSOCIATED WITH AN INCREASE IN MAJOR ADVERSE CARDIOVASCULAR EVENTS
    Michel, Adrian
    Mando, Ramy
    Waheed, Muhammad Abdul-Aziz
    Halalau, Alexandra
    Karabon, Patrick
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 14 - 14
  • [9] Systematic review and meta-regression on the duration of LDL-C lowering and major adverse cardiovascular events
    Redel-Traub, Gabriel
    Smilowitz, Nathaniel R.
    Xia, Yuhe
    Berger, Jeffrey S.
    VASCULAR MEDICINE, 2022, 27 (04) : 375 - 376
  • [10] Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
    Peluso, Rosario
    Caso, Francesco
    Tasso, Marco
    Ambrosino, Pasquale
    Di Minno, Matteo Nicola Dario
    Lupoli, Roberta
    Criscuolo, Livio
    Caso, Paolo
    Ursini, Francesco
    Del Puente, Antonio
    Scarpa, Raffaele
    Costa, Luisa
    REVIEWS ON RECENT CLINICAL TRIALS, 2018, 13 (03) : 199 - 209
12345